ZAQS.ORG

Bessent blames Lutnick's Commerce as he slams Nvidia chip 'leakage' to China

2 hours ago

Microsoft apologizes for massive outage that took down Outlook and other 365 services

9 minutes ago

The common theme driving stocks lower — plus, 3 trades and another we want to make

9 minutes ago

Lutnick faces questions over Nvidia spy scandal. His sons' firm has deep ties to the chipmaker

9 minutes ago

Goldman Sachs looks to cash in on Anthropic's IPO, twice. Here's how and who else wants to

9 minutes ago

Feds arrest top official of healthcare company, alleging illegal drug importation

1 day ago

Measles is surging in the U.S. — and outbreaks can cost millions

2 days ago

FDA warns of vision loss risk linked to GLP-1 drugs like Wegovy, Zepbound

2 days ago

Eli Lilly's obesity pill eases sleep apnea in late-stage trial

3 days ago

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

4 days ago

Could CRISPR cure rare diseases before birth? Scientists are getting closer

2 days ago

Moderna hikes 2026 sales growth outlook, smashes quarterly estimates

2 days ago

Jim Cramer says the AI trade is not going away as Nasdaq enters correction

8 days ago

CVS Health plans to split itself up. Here's why a breakup could make sense now

8 days ago

Jim Cramer says this bank stock is a buy after its post-election pullback

9 days ago

CVS falls on plans to split off drugstore business in major breakup

9 days ago

Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook

9 days ago

Pfizer hikes 2026 outlook as new products grow, taps company veteran as new CFO

9 days ago

Midterm elections could jolt stocks as Democrats look poised to sweep Congress

9 days ago

A biotech's high-stakes cancer bet just paid off and its shares doubled

10 days ago

Jim Cramer says lower oil prices are giving stocks a boost. Can it last?

10 days ago

Stocks started the week higher but ended in despair. Our take on the big reversal

10 days ago

Cramer's week ahead: Expect more volatility as tech earnings, midterms loom

13 days ago

Gen Z is ditching bars for run clubs — and finding more than friends along the way

14 days ago

A pharma major is touting an MS drug to ease patent-cliff fears

14 days ago

West Pharma: More than a GLP-1 play. The case for further upside

14 days ago

Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx

15 days ago

Merck tops estimates, hikes profit outlook on strength of injectable Keytruda

15 days ago

Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand

15 days ago

GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers

15 days ago

Measles resurgence exposes deeper weaknesses in U.S. public health, experts say

17 days ago

Cramer: I asked tech insiders what to buy. They surprisingly said this drug stock

17 days ago

Amgen says drug combo slashes risk of death by 58% in patients with lung cancer

18 days ago

Doctors call Moderna, Merck's cancer vaccine data a major advancement

20 days ago

Moderna shares plunge after cancer vaccine data leaks — despite positive results

21 days ago

New bipartisan bill aims to speed up clinical trials for rare disease treatments

22 days ago

Novo's CagriSema obesity drug shows 25% weight loss in women in analysis

22 days ago